Aligos Therapeutics
ALGS
ALGS
52 hedge funds and large institutions have $612M invested in Aligos Therapeutics in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.03% less ownership
Funds ownership: 2.86% → 2.83% (-0.03%)
18% less capital invested
Capital invested by funds: $749M → $612M (-$137M)
Holders
52
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$7.34M | |
| 2 | +$1.9M | |
| 3 | +$1.63M | |
| 4 |
Goldman Sachs
New York
|
+$950K |
| 5 |
Millennium Management
New York
|
+$741K |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$2.96M | |
| 3 | -$2.05M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.38M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$821K |